These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33746950)
1. Modulation of Liver Inflammation and Fibrosis by Interleukin-37. Mountford S; Effenberger M; Noll-Puchta H; Griessmair L; Ringleb A; Haas S; Denk G; Reiter FP; Mayr D; Dinarello CA; Tilg H; Bufler P Front Immunol; 2021; 12():603649. PubMed ID: 33746950 [No Abstract] [Full Text] [Related]
2. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways. Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis. Yang JH; Kim KM; Cho SS; Shin SM; Ka SO; Na CS; Park BH; Jegal KH; Kim JK; Ku SK; Lee HJ; Park SG; Cho IJ; Ki SH Antioxid Redox Signal; 2019 Jul; 31(3):243-259. PubMed ID: 30909713 [No Abstract] [Full Text] [Related]
10. Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation. López-Navarrete G; Ramos-Martínez E; Suárez-Álvarez K; Aguirre-García J; Ledezma-Soto Y; León-Cabrera S; Gudiño-Zayas M; Guzmán C; Gutiérrez-Reyes G; Hernández-Ruíz J; Camacho-Arroyo I; Robles-Díaz G; Kershenobich D; Terrazas LI; Escobedo G Int J Biol Sci; 2011; 7(9):1273-86. PubMed ID: 22110380 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells. Tan Z; Liu Q; Jiang R; Lv L; Shoto SS; Maillet I; Quesniaux V; Tang J; Zhang W; Sun B; Ryffel B Cell Mol Immunol; 2018 Apr; 15(4):388-398. PubMed ID: 28194023 [TBL] [Abstract][Full Text] [Related]
12. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl Wang R; Zhang D; Tang D; Sun K; Peng J; Zhu W; Yin S; Wu Y Int Immunopharmacol; 2021 Jan; 90():107151. PubMed ID: 33296784 [TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases. García-Ruiz I; Blanes Ruiz N; Rada P; Pardo V; Ruiz L; Blas-García A; Valdecantos MP; Grau Sanz M; Solís Herruzo JA; Valverde ÁM Redox Biol; 2019 Sep; 26():101263. PubMed ID: 31299613 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 participates in the progression from liver injury to fibrosis. Gieling RG; Wallace K; Han YP Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1324-31. PubMed ID: 19342509 [TBL] [Abstract][Full Text] [Related]
19. Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992 [TBL] [Abstract][Full Text] [Related]